IOVA Operating Cash Flow Growth
Iovance Biotherapeutics Inc · Operating Cash Flow Growth
IOVA Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported9.79%period ending
IOVA Quarterly Cash from Operations YoY % (95.22% → 9.79%)
Year-over-year change
High-resolution chart · PNG
IOVA operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 9.7944% | |
| 30.4936% | |
| 28.2839% | |
| -33.4543% | |
| 31.4765% | |
| 15.1988% | |
| 12.7117% | |
| 29.8633% | |
| -4.7652% | |
| -22.5056% | |
| -8.1098% | |
| -32.1042% | |
| -21.0176% | |
| -35.247% | |
| -44.2385% | |
| -10.3236% | |
| -43.7472% | |
| -18.2895% | |
| 14.1055% | |
| -42.3991% | |
| -47.4219% | |
| 4.4431% | |
| -16.4802% | |
| 3.9519% | |
| -8.4036% | |
| -124.4483% | |
| -70.5981% | |
| -51.0384% | |
| -41.2657% | |
| -62.9783% | |
| -50.4913% | |
| -30.2248% | |
| -36.7341% | |
| 5.0737% | |
| -72.4155% | |
| -75.6573% | |
| -366.809% | |
| -313.0712% | |
| -84.8153% | |
| -217.6597% | |
| 16.7098% | |
| -31.6121% | |
| -98.4657% | |
| -122.322% | |
| -240.3389% | |
| -52.5406% | |
| -47.1216% | |
| -304.7933% | |
| -93.8898% | |
| -655.7877% | |
| -133.8582% | |
| -52.1246% | |
| 43.1968% | |
| 60.5376% | |
| 345.5952% | |
| 82.9804% | |
| 5.1405% | |
| -34.6768% | |
| -633.1474% | |
| -1,355.6142% | |
| -1,438.2357% | |
| -914.896% | |
| -2,939.158% | |
| -21,041.791% | |
| -19,772.9469% | |
| -4,059.985% | |
| 12.1759% | |
| 45.749% | |
| 97.1468% | |
| 95.2178% |